Vijaya Diagnostic Centre Intrinsic Value
Vijaya Diagnostic Centre (VIJAYA) median intrinsic value is ₹710.40 from 9 valuation models (range ₹449–₹3022), vs current price ₹1497.30 — -52.6% downside (Trading Above Calculated Value), margin of safety -100.0%. Read VIJAYA dividend track record for the complete payout history and dividend yield track record.
VIJAYA Valuation Methods Summary — DCF, Graham Number & P/E
Vijaya Diagnostic Centre intrinsic value across 9 models vs current price ₹1497.30 — upside/downside and value range per method. Analyse Vijaya Diagnostic Centre ownership structure to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹449.19 | ₹359.35 - ₹539.03 | -70.0% | EPS: ₹18.64, Sector P/E: 12x |
| Book Value Method | asset | ₹957.00 | ₹861.30 - ₹1052.70 | -36.1% | Book Value/Share: ₹957.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹710.40 | ₹639.36 - ₹781.44 | -52.6% | Revenue/Share: ₹888.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹2352.00 | ₹2116.80 - ₹2587.20 | +57.1% | EBITDA: ₹392.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹3022.31 | ₹2417.85 - ₹3626.77 | +101.9% | CF Growth: 14.7%, Discount: 15% |
| PEG Ratio Method | growth | ₹449.19 | ₹404.27 - ₹494.11 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹449.19 | ₹404.27 - ₹494.11 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹2994.60 | ₹2695.14 - ₹3294.06 | +100.0% | ROE: 20.1%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹633.53 | ₹570.18 - ₹696.88 | -57.7% | EPS: ₹18.64, BVPS: ₹957.00 |
VIJAYA Intrinsic Value vs Market Price — All Valuation Models
Vijaya Diagnostic Centre fair value range ₹449–₹3022 vs current market price ₹1497.30 across 9 valuation models. For current market price and key ratios, visit VIJAYA screener.
VIJAYA Intrinsic Value Analysis — Undervalued or Overvalued?
Vijaya Diagnostic Centre median intrinsic value ₹710.40, current price ₹1497.30 — Trading Above Calculated Value by 52.6%, margin of safety -100.0%.
What is the intrinsic value of VIJAYA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Vijaya Diagnostic Centre (VIJAYA) is ₹710.40 (median value). With the current market price of ₹1497.30, this represents a -52.6% variance from our estimated fair value.
The valuation range spans from ₹449.19 to ₹3022.31, indicating ₹449.19 - ₹3022.31.
Is VIJAYA undervalued or overvalued?
Based on our multi-method analysis, Vijaya Diagnostic Centre (VIJAYA) appears to be trading above calculated value by approximately 52.6%.
VIJAYA Financial Health — Key Ratios vs Industry Benchmarks
Vijaya Diagnostic Centre financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.76 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 20.1% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 44.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.59x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
VIJAYA Cash Flow Quality — Operating & Free Cash Flow
Vijaya Diagnostic Centre operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹225 Cr | ₹134 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹183 Cr | ₹113 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹165 Cr | ₹110 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹158 Cr | ₹97 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹130 Cr | ₹65 Cr | Positive Free Cash Flow | 7/10 |